Neurophysiological Deficits During Reappraisal of Negative Emotional Stimuli in Opioid Misuse.
Neurophysiological Deficits During Reappraisal of Negative Emotional Stimuli in Opioid Misuse.
复制标题
DOI:
10.1016/j.biopsych.2022.01.019
复制
发表时间:
2022-06-15
影响因子:
10.6
通讯作者:
中科院分区:
文献类型:
--
作者:
Opioid misuse is hypothesized to compromise the ability to regulate negative emotions, as manifested through visceral and peripheral physiological signals. However, neurophysiological impairment of top-down cognitive emotion regulation in opioid misuse has not previously been shown. Patients with chronic pain who had been taking opioids for 90 days or longer (N=149; Female n=98) underwent a negative emotion regulation task with electroencephalography (EEG). Participants were instructed to view or reappraise negative images presented for 3 s. Using a validated cutoff score on the Current Opioid Misuse Measure, participants were classified as exhibiting aberrant drug-related behavior consistent with opioid misuse (MISUSE+) or as being low risk for opioid misuse (MISUSE-). Participants reported their general opioid craving in the past week and craving in response to negative emotions. We observed a group X condition interaction (p=0.003), such that the MISUSE- group decreased the late positive potential (LPP) of the EEG during reappraisal whereas the MISUSE+ group showed increased LPP during reappraisal. This deficit in negative emotion regulation remained significant after controlling for an array of potential confounding variables, including opioid dose, pain, and depression. Heightened LPP during reappraisal was associated with more severe opioid craving. Opioid misuse can occasion top-down deficits in emotional regulation that begin as early as 400 milliseconds after presentation of negative stimuli. It remains unknown whether emotion dysregulation is the cause, correlate, or consequence of opioid misuse. Nonetheless, targeting emotion dysregulation in opioid misuse with reappraisal-focused interventions may represent an important treatment approach.
登录
查看更多内容
DOI:
10.1016/j.jpain.2008.10.008
发表时间:
2009-02
期刊:
The journal of pain
影响因子:
--
作者:
Chou R;Fanciullo GJ;Fine PG;Adler JA;Ballantyne JC;Davies P;Donovan MI;Fishbain DA;Foley KM;Fudin J;Gilson AM;Kelter A;Mauskop A;O'Connor PG;Passik SD;Pasternak GW;Portenoy RK;Rich BA;Roberts RG;Todd KH;Miaskowski C;American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel
通讯作者:
American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel
影响因子:
25.8
作者:
Froeliger B;McConnell PA;Bell S;Sweitzer M;Kozink RV;Eichberg C;Hallyburton M;Kaiser N;Gray KM;McClernon FJ
通讯作者:
McClernon FJ
影响因子:
5.9
作者:
Garland, Eric L.;Hanley, Adam W.;Howard, Matthew O.
通讯作者:
Howard, Matthew O.
影响因子:
2.6
作者:
Cuthbert, BN;Schupp, HT;Lang, PJ
通讯作者:
Lang, PJ
影响因子:
39
作者:
Garland EL;Hanley AW;Nakamura Y;Barrett JW;Baker AK;Reese SE;Riquino MR;Froeliger B;Donaldson GW
通讯作者:
Donaldson GW